Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 11, 1998

View Archived Issues

Flamels Genvir For Herpes Shows Strong Phase III Data

Stanford Rook Changes Name, Starts Cancer Drugs Phase III

Biomira, Plant Vaccine Firm Partner For Cancer Compounds

Adult Tooth Replacement By Gene Expression Could Be Wave Of Dental Future

Agis Buys Stake In Pharmos, Becomes Largest Shareholder

Trinity Biotech Earnings Up; HIV Test Marketing Expands

U.K. Officials, Insurers Join To Validate Genetic Testing

Phytopharm, Heska Sign Deal Covering Botanical Pet Drugs

Treatment Of Blood Clots Explored By Two Groups

Cambridge Antibodys RA Drug Proving Effective In Early Data

Other News To Note

BioVision Aims To Bridge Japanese, U.S. Biotech

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....